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Abstract
Recently, a number of different approaches have been used to examine variation in gene expression
and to identify genes whose level of transcript differed greatly among unrelated individuals.
Previous studies have commonly focused on identifying determinants that regulate gene
expressions by targeting individual genes. However, it is difficult to detect true differences in the
level of gene expression among genotypes from noise due to issues such as multiple testing and
limited sample size. To increase the statistical power for detecting this difference, we consider a
'gene set' approach by focusing on subtle but coordinated changes in gene expression across
multiple genes rather than individual genes. We defined a 'gene set' as a set of genes in the same
biological pathway and focused on identifying common regulators based on an assumption that the
genes within the same pathway are controlled by common regulators. We applied the gene set
approach to the expression data of mRNA in Centre d'Etude du Polymorphisme Humain
lymphoblast cells to identify regulators controlling the genes in a biological pathway. Our gene set
approach successfully identified potent regulators controlling gene expression in an inflammatory
response pathway.
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Background
In the past 2 years, profiling gene expression has become
popular in the field of human genetics as various poly-
morphic functions located on the human genome have
been characterized in the context of large-scale gene
expression studies [1-5]. Understanding the genetic mech-
anisms controlling gene expression will give an insight
into the functional elements of the human genome, and
ultimately reveal functional polymorphisms affecting the
risks associated with certain human diseases [6].
In previous studies, researchers have focused on identify-
ing the expression quantitative trait loci (eQTL) that regu-
late gene expression by targeting individual genes.
However, issues such as multiple testing, variations in
expression across individuals, and limited sample size in
human studies make it difficult to discern true differences
in the level of gene expression from noise, particularly
where alterations in gene expression among genotypes are
modest. These problems have been well defined in analy-
ses of microarray data, and several approaches have been
suggested to increase the statistical power to detect this
difference. It is by focusing on subtle but coordinated
changes in gene expression across multiple genes in a gene
set rather than individual genes that the most promising
route to a solution is to be found [7].
In using the concept of 'gene set', we consider a two-step
procedure to the analysis of the Genetic Analysis Work-
shop 15 (GAW15) Problem 1 data to identify regulators
controlling the functional pathways in lymphoblast cells.
The first step uses a peak identification algorithm (PIA) to
detect genetic markers with relatively high and similar sig-
nificance patterns in the same pathway. The second step
applies Fisher's exact test to detect the common regulator
(peak) of the pathway, under the assumption that the
number of peaks at a specific marker has the same distri-
bution as that for all other markers.
Methods
Identifying eQTL for a single gene
In this study, expression profiles for 8798 transcripts and
genotype variations for 2882 single-nucleotide polymor-
phisms (SNPs) were selected. A multipoint genome-wide
linkage analysis was performed using SIBPAL, a sub-rou-
tine of the Statistical Analysis for Genetic Epidemiology
(S.A.G.E) software package. Pair-wise phenotype differ-
ences between siblings were weighted using an option
('W4') of SIBPAL.
Defining gene set by functional pathway
We defined a 'gene set' as a set of genes with a common
biological pathway. Information on the pathway was
obtained from four different sources to assign genes to
each of the pathways: Kyoto Encyclopedia of Genes and
Genomes (KEGG) [8], Gene Map Annotator and Pathway
Profiler (GenMAPP) [9], Pharmacogenetics and Pharma-
cogenomics Knowledge Base (PharmGKB) [10], and Bio-
Carta http://www.biocarta.com. There are 467 different
gene sets. Each gene set contains various numbers of
genes, ranging from 5 to 53.
Peak identification
In order to detect genetic markers with relatively high and
similar patterns of p-values to other genes in the same
pathway, we applied the PIA. The PIA uses smoothing
methods, which have the advantage of enhancing peaks
and getting rid of spurious peaks by using the average of
neighboring peaks.
First, we transformed the p-value from a multipoint
genome-wide linkage analysis to s  = -log(p-value). The
higher value of s indicates the stronger effect of the marker
on the level of gene expression. Next, we searched the
peaks of s in the gene expression data for all SNP markers
located on each gene. The values of s were first smoothed
using the local variations from the nearest neighbors.
Then potential peaks were identified using Ripley's K
function [11]. In this study, the 'PROcess' of R package
was used to identify these peaks http://www.bioconduc
tor.org.
Detecting significant markers in the common pathway
Once peaks showing the significant effects on expression
level of each gene were identified, the common peaks in a
set of genes were sought. We assumed that the number of
peaks at specific markers across genes has a hypergeomet-
ric distribution under the null hypothesis that the number
of peaks of genes at a specific marker has the same distri-
bution as that for all other markers. We tested the signifi-
cance of sharing peaks at all specific markers across genes
using Fisher's exact test.
Results
Because our gene expression data were obtained from a
lymphoblastic cell line, we focused on four different path-
ways directly related to immune systems, namely the
'inflammatory response pathway', 'glucocorticoid and
inflammatory genes pathway', 'glucocorticoid and inflam-
matory genes pathway gene regulation', and 'cytokines
and inflammatory response pathway'. These pathways
contain 23, 7, 5, and 24 genes, respectively. Among these
four pathways, only 'inflammatory response pathway'
showed a significant result. Here, we present the results of
a multipoint linkage test, peak identification, and sum-
mary peaks of genes related to this pathway.
Identifying eQTL for a single gene
The results of a multipoint linkage analysis for the 23
genes are shown in Table 1. The threshold of p-values inBMC Proceedings 2007, 1(Suppl 1):S90 http://www.biomedcentral.com/1753-6561/1/S1/S90
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this linkage analysis was 7.903701 × 10-5 (e.g., adjusted
significant level of 0.01 using the Bonferroni correction).
The three significant eQTL regions controlling gene
expression level were identified from the 23 genes. These
three regions are unlinked (Table 1), so it could not be
determined whether the corresponding QTLs work in
coordination or act independently on the pathway.
Peak identification
The 23 genes in the 'inflammatory response pathway'
were smoothed using the nearest neighboring peaks. Then
we found peaks of s value using the PIA. Figure 1A shows
the smoothed s values and the local variances across all
chromosomes. The blue line represents the smoothed
peaks, the red circles represent the peaks selected, and the
black line represents the local variance.
Detecting significant markers in the common pathway
Four significant markers were identified by Fisher's exact
tests. The negative log p-values from Fisher's exact test for
genome-wide markers are shown in Figure 2. The red line
indicates the threshold of p-values adjusted by the Bonfer-
roni correction. Markers showing statistical significances
and their positions are shown in Table 2. Among the four
markers, the lowest p-value 1.5787 × 10-9 was observed at
rs766737, which is linked to the regulator of the 'inflam-
matory response pathway'. The six different genes among
the 23 genes shared common peaks at rs766737 located
on chromosome 14 (Figure 1B).
Discussion and conclusion
In this study, we proposed a method to integrate genetic
data and gene expression data based on the gene set
approach. We defined a 'gene set' as a set of genes in the
same biological pathway and focused on identifying com-
mon regulators based on an assumption that genes within
the same pathway are controlled by common regulators,
either directly or indirectly. However, the genes in the low
cascade of the pathway are not easily detected by using a
classical linkage analysis with a strict threshold adjusting
for multiple comparison problems, even though these
genes are controlled by common regulators.
We, therefore, proposed a two-step procedure for detect-
ing pathway regulators. In the first step, we performed the
PIA to detect p-values in a multipoint linkage analysis. The
PIA allowed us to choose markers controlling subtle over-
all changes in gene expression levels. Once peaks were
identified, the peaks of a specific gene were compared to
those of other genes in the same pathway, in the second
step. For detecting the common peaks of genes within the
same pathway at a specific marker, we performed Fisher's
exact test and obtained one potent regulator for the
inflammatory response pathway.
Table 1: eQTLs of Genes involved in the Inflammatory response pathway
Gene Probe ID Gene name Gene position eQTL region (Mb)
LAMC1 200771_at laminin, gamma 1 1q31 None
LAMB1 201505_at laminin, beta 1 7q22 None
LAMC2 202267_at laminin, gamma 2 1q25-q31 None
COL1A1a 202310_s_at collagen, type I, alpha 1 17q21.33 Chromosome X (137.0~149.8)
COL1A2 202403_s_at collagen, type I, alpha 2 7q22.1 None
IL4R 203233_at interleukin 4 receptor 16p11.2-12.1 None
IL2RG 204116_at interleukin 2 receptor, gamma Xq13.1 Chromosome X (24.0~32.0)
VTN 204534_at Vitronectin 17q11 None
LCK 204891_s_at lymphocyte-specific protein tyrosine kinase 1p34.3 None
IL2RB 205291_at interleukin 2 receptor, beta 22q13.1 None
CD86 205686_s_at CD86 molecule 3q21 None
CD28 206545_at CD28 molecule 2q33 None
CD80 207176_s_at CD80 molecule 3q13.3-q21 None
IL4 207539_s_at interleukin 4 5q31.1 None
MUC1 207847_s_at mucin 1, cell surface associated 1q21 None
IL2 207849_at interleukin 2 4q26-q27 None
CD40LG 207892_at CD40 ligand Xq26 Chromosome17 (79.0~85.0)
IL5 207952_at interleukin 5 5q31.1 None
THBS3 209561_at thrombospondin 3 1q21 None
IFNG 210354_at interferon gamma 12q14 None
IL2RA 211269_s_at interleukin 2 receptor, alpha 10p15-p14 None
IL5RA 211516_at interleukin 5 receptor, alpha 3p26-p24 None
LAMB2 216264_s_at laminin, gamma 1 1q31 None
aBold text indicates the significant eQTL region.BMC Proceedings 2007, 1(Suppl 1):S90 http://www.biomedcentral.com/1753-6561/1/S1/S90
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When we applied the gene set approach to the GAW 15
Problem 1 data, there were significant differences in
results between the classical eQTL approach and the gene
set approach. First of all, the classical eQTL approach only
detected 3 genes with significant eQTL among the 23
genes. However, these 3 eQTLs are not linked, so we were
unable to conclude whether or not these genes are regu-
lated by the same regulators. On the other hand, the gene
set approach identified a significant common regulator
controlling gene expressions in the 'inflammatory
response pathway'. The most significant marker,
The result of peak identification and detecting common significant marker Figure 1
The result of peak identification and detecting common significant marker. A, The blue line represents the 
smoothed peaks, the red circles represent the peaks selected, and the black line represents the local variances. B, Peak identi-
fication of markers on chromosome 14. The markers in the red box represent the significant common markers of the inflam-
matory response pathway.BMC Proceedings 2007, 1(Suppl 1):S90 http://www.biomedcentral.com/1753-6561/1/S1/S90
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rs766737, is located within 2 kb from a mRNA transcript
for the T cell receptor alpha locus (TRA@) on 14q11.2.
The T cell receptor (TCR) is a molecule found on the sur-
face of T lymphocytes that is responsible for recognizing
antigens bound to major histocompatibility complex
(MHC) molecules. The TCRs recognize foreign antigens,
and then convey the message to the nucleus to induce an
inflammatory response [12]. Our bodies produce many T
cells, each with specific TCRs on their surfaces through the
recombination of the genes that encode the receptors,
before they have encountered complementary antigens.
Thus, the gene set approach convinced us that the geno-
type variation in a TCR has an effect on the expression
level of genes in an inflammatory response pathway.
Our method has two advantages over the classical eQTL
approach. First, it makes possible to obtain a more func-
tional inference of the result on the basis of the biological
pathway. Using prior knowledge we were able to obtain
regulators of the whole pathway rather than individual
genes. Second, it makes possible to detect relatively small
but global effects on the genes interacting in the same
pathway.
The proposed method can be further extended. The cur-
rent method does not consider any linkage disequilib-
rium block structures. We think a test for significant
regions using flanking markers could improve the power
of detection of the common regulators.
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